BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4702294)

  • 1. [Anti-androgenic therapy for prostate carcinoma].
    Schoonees R
    S Afr Med J; 1973 May; 47(17):722-4. PubMed ID: 4702294
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiandrogen effects on canine prostatic secretion.
    Schoonees R; Reynoso G; De Klerk JN; Murphy GP
    Invest Urol; 1973 May; 10(6):434-7. PubMed ID: 4704168
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis of the anti-androgenic effect of a new diphenylethylene derivate (F 63) and diethylstilbestrol (DES).
    Johnson L; Nylander G; Wikström S
    Acta Soc Med Ups; 1967; 72(5):313-30. PubMed ID: 5628588
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of androgen on canine prostatic secretion.
    Schoonees R; Reynoso G; Murphy GP
    J Surg Oncol; 1972; 4(3):169-79. PubMed ID: 5069801
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyproterone acetate in the treatment of advanced carcinoma of the prostate.
    Smith RB; Walsh PC; Goodwin WE
    J Urol; 1973 Jul; 110(1):106-8. PubMed ID: 4713345
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of cyproterone acetate in animal and clinical trials.
    Neumann F
    Gynecol Invest; 1971; 2(1):150-79. PubMed ID: 4949823
    [No Abstract]   [Full Text] [Related]  

  • 7. The combination of cyproterone acetate and low dose diethylstilbestrol in the treatment of advanced prostatic carcinoma.
    Goldenberg SL; Bruchovsky N; Rennie PS; Coppin CM
    J Urol; 1988 Dec; 140(6):1460-5. PubMed ID: 2973529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiologic basis for hormonal theapy in carcinoma of the prostate.
    Walsh PC
    Urol Clin North Am; 1975 Feb; 2(1):125-40. PubMed ID: 48206
    [No Abstract]   [Full Text] [Related]  

  • 9. The composition of nerve induced canine prostatic secretion.
    Smith ER; Lebeaux M
    Invest Urol; 1971 Sep; 9(2):100-3. PubMed ID: 5165999
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative effects and mechanisms of castration, estrogen anti-androgen, and anti-estrogen-induced regression of accessory sex organ epithelium and muscle.
    Neubauer B; Blume C; Cricco R; Greiner J; Mawhinney M
    Invest Urol; 1981 Jan; 18(4):229-34. PubMed ID: 7451082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience in the treatment of prostatic carcinoma with cyproterone acetate.
    Wein AJ; Murphy JJ
    J Urol; 1973 Jan; 109(1):68-70. PubMed ID: 4684552
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of oestrogen on phosphatase activity in the ventral prostate of intact, castrated, and androgen-treated castrated, adult rats.
    Andersson M; Müntzing J
    Acta Pharmacol Toxicol (Copenh); 1971; 30(3):193-202. PubMed ID: 5171939
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical-pharmacological investigation of cyproterone acetate.
    van Wayjen RG; van den Ende A
    Gynecol Invest; 1971; 2(1):282-9. PubMed ID: 5161488
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of cyproterone acetate on advanced carcinoma of the prostate.
    Geller J; Vazakas G; Fruchtman B; Newman H; Nakao K; Loh A
    Surg Gynecol Obstet; 1968 Oct; 127(4):748-58. PubMed ID: 5675191
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of ethinylestradiol and cyproterone acetate on androgen metabolism by the human prostate gland.
    Briggs MH; Briggs M
    J Clin Endocrinol Metab; 1973 Mar; 36(3):600-4. PubMed ID: 4685394
    [No Abstract]   [Full Text] [Related]  

  • 16. Reversible inhibition of spermatogenesis in men.
    Petry R; Mauss J; Rausch-Stroomann JG; Vermeulen A
    Horm Metab Res; 1972 Sep; 4(5):386-8. PubMed ID: 4645935
    [No Abstract]   [Full Text] [Related]  

  • 17. Initiation of LHRH monotherapy for prostate cancer.
    Milsted RA
    Prog Clin Biol Res; 1989; 303():69-74. PubMed ID: 2528742
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential effects of estrogen treatment on canine seminal plasma components.
    Isaacs JT; Isaacs WB; Wheaton LG; Coffey DS
    Invest Urol; 1980 May; 17(6):495-8. PubMed ID: 6154670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of diethylstilbestrol on blood glucose of prostatic cancer patients.
    Sotaniemi EA; Kontturi M; Larmi TK
    Ann Chir Gynaecol Fenn; 1973; 62(2):82-6. PubMed ID: 4717366
    [No Abstract]   [Full Text] [Related]  

  • 20. Total androgen suppression in the management of prostatic cancer. A critical review.
    Schroeder FH
    Prog Clin Biol Res; 1985; 185A():307-17. PubMed ID: 3898133
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.